Abstract
Induced nitric oxide (NO), the end product of the enzyme inducible nitric oxide synthase (iNOS), has been shown to be an important mediator in a number of human diseases and cancers [1–4]. L-arginine is converted to the NO and L-citrulline by the inducible isoform of nitric oxide synthase and produces high levels of NO (Fig. 1). Once produced, NO has a short half-life (t1/2 = s) and undergoes spontaneous oxidation to the inactive metabolites nitrite and nitrate (NO2 - and NO3 -). Because iNOS is involved in the pathogenesis of the inflammatory response, the characterization of the cis- and trans-activating factors which regulate lipopolysacharide-(LPS) and cytokine-induced iNOS expression have been pursued. This review will summarize and contrast the molecular regulation of the murine and human iNOS genes. The regulation of iNOS is complex and occurs at multiple sites within the signal transduction pathways that lead to iNOS gene expression and includes transcription and post-transcriptional mechanisms of modification.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Moncada S, Higgs EA (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur J Clin Invest 21: 361–374
Szabo C, Thiemermann C (1994) Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 2(2): 145–155
Kolb H, Kolb-Bachofen V (1998) Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol Today 19: 556–561
Kronke KD, Fehsel K, Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113: 147–156
Nussler A, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madriaga J, Simmons RL (1992) Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176: 261–264
Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvo M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491–3495
Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH (1992) Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 89: 6711–6715
Xie Q, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225–28
Lyons CR, Orloff GJ, Cunningham JM (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370–6374
Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T (1992) Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307: 287–293
Janssens SP, Shimouchi A, Quertermous T, Bloch DB (1992) Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267(21): 14519–14522
Nakane M, Schmidt HHHW, Pollock JS, Forstermann U, Murad F (1993) Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316: 175–180
Geller DA, Billiar TR (1998) Molecular biology of nitric oxide synthases. Cancer Metast Rev 17: 7–23
Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S (1993) Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90: 11419–11423
Maier R, Bilbe G, Rediske J, Cotz M (1994) Inducible nitric oxide synthase from articular human chondrocytes: cDNA, cloning and analysis of mRNA expression. Biochem Biophys Acta 1208: 145–150
Sherman PA, Laubach VE, Reep BR, Wood ER (1993) Purification and cDNA sequence of an inducible nitric oxide synthase (NOS) from a human tumor cell line. Biochem 32: 11600–11605
Hokari A, Zeniya M, Esumi H (1994) Cloning and functional expression of human inducible nitric oxide synthase (NOS) from a glioblastoma cell line A-172. J Biochem 116: 575–581
Luss H, Watkins SC, Freeswick PD, Imro AK, Nussler AK, Billiar TR, Simmons RL, del Nido PJ, McGowan FX Jr (1996) Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J Mol Cell Cardiol 27: 2015–2029
Chartrain N, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS (1994) Molecular cloning, structure, chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269: 6765–6772
Marsden PA, Heab HHQ, Scherer SW, Stewart RJ, Hall AV et al (1993) Structural and chromosomal localization of the human constituitive endothelial nitric oxide synthase. J Biol Chem 268: 17478–17488
Kishimoto J, Spurr N, Liao M, Lizhi L, Emsonp Xu W (1992) Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 14: 802–804
Taylor BS, Geller DA (2000) Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene (Review). Shock 13: 413–424
Xie QW, Whisnant R, Nathan C (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confrs inducibility by inter feron-γ and bacterial LPS. J Exp Med 177: 1779–1785
Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ: Macrophage nitric oxide synthase gene (1993) two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci USA 90: 9730–9738
Xie Q-w, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269: 4705–4708
Xie Q-w (1997) A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J Biol Chem 272(23): 14867–14872
Taylor, BS, de Vera, ME, Ganster, RW, Wang, Q, Shapiro, RA, Morris, SM, Billiar TR, Geller DA (1998) Multiple NFκB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273: 15148–15156
Goldring CE, Reveneau S, Algarte M, Jeannin JF 1996) In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. Nucleic Acids Research 24(9): 1682–1687
Sawada T, Falk LA, Padmini R, Murphy WJ, Pluznik DV (1997) IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: Role of octamer binding proteins. J Immunol 158: 5267–5276
Gay RD, Dawson SJ, Murphy WJ, Russell SW, Latchman DS (1998) Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter. Bioch Biophy Acta-Gene Structure and Expression 1443(3): 315–322
Dlaska M, Weiss G (1999) Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J Immunol 162: 6171–6177
Martin E, Nathan C, Xie QW (1994) Role of interferon regulatory factor 1 in inducton of nitric oxide synthase. J Exp Med 180(3): 977–984
Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ (1997) An interferon-g-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and LPS. J Biol Chem 272: 1226–1230
Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ (1998) Autocrine/paracrine IFN-αβ mediates the lipopolysaccharide-induced activation of transcription factor Stat1α in mouse macrophages: Pivotal role of Staila in induction of the inducible nitric oxide synthase gene. J Immunol 161: 4803–4810
Murphy WJ, Muroi M, Zhang CX, Suzuki T, Russell SW (1996) Both basal and enhancer elements are required for full induction of the mouse inducible nitric oxide synthase gene. J Endotoxin Res 3: 381–393
Spink, J, Cohen J, Evans TJ (1995) The cytokine responsive vascular smooth musle cell enhancer of inducible nitric oxide synthase. J Biol Chem 270: 29541–29547
Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L (1995) A hypoxia responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 182: 1683–1693
Zhang X, Laubach VE, Alley EW, Edwards KA, Sherman PA, Russell SW, Murphy WJ (1996) Transcriptional basis for hyporesponsiveness of human inducible nitric oxide synthase gene to lipopolysaccharide/interferon-γ. J Leukocyte Biol 59: 575–585
Spitsin SV, Farber JL, Bertovich M, Moehren G, Koprowski H, Michaels FH (1997) Human-and mouse-inducible nitric oxide synthase gene promoters require activation of phosphatidylcholine-specific phospholipase C and NF-γB. Mol Med 3: 315–326
Bertholet S, Tzeng E, Felley-Bosco E, Mauel J (1999) Expression of the induciible nitric oxide synthase in human monocytic U937 cells allows high output nitric oxide production. J Leukoc Biol 65: 50–58
Geller DA, de Vera ME, Russell DA, Shapiro RA, Nussler AK, Simmons RL, Billiar TR 1995) A central role for interleukin-1β in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. J Immunol 155: 4890–4898
Arany I, Brysk MM, Brysk H, Tyring SK (1996) Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. Biochem Biophys Res Commun 220: 618–622
Nussler AK, Vergani G, Gollin SM, Dorko K, Morris SM Jr, Demetris AJ, Nomoto M, Beger HG, Strom SC (1999) Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver. In vitro Cellular & Developmental Biology 35: 190–197
de Vera ME, Shapiro RA, Nussler AK, Mudgett JS., Simmons RL, Morris SM, Billiar TR, Geller DA 1996) Transcriptional regulation of human inducible nitric oxide synthase (iNOS) gene by cytokines: Initial analysis of the human iNOS promoter. Proc Natl Acad Sci USA 93: 1054–1059
Laubach, VE, Zhang CX, Russell SW, Murphy WJ, Sherman PA (1997) Analysis of expression and promoter function of the human inducible nitric oxide synthase gene in DLD-1 cells and monkey hepatocytes. Biochim Biophys Acta 1351: 287–295
Marks-Konczalik J, Chu SC, Moss J (1998) Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor-γB-binding sites. J Biol Chem 273: 22201–22208
Kolyada AY, Savikovsky N, Madias NE (1996) Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem Biophys Res Commun 220: 600–605
Linn, SC, Morelli PJ, Edry I, Cottongim SE, Szabo C, Salzman AL (1997) Transcriptional regulation of human inducible nitric oxide synthase in an intestinal epithelial cell line. Am J Physiol 35: G1499–G1508
Taylor, BS, Shao, LF, Gambotto, A, Ganster, RW, Geller, DA (1999) Inhibition of cytokine-induced nitric oxide synthase (iNOS) expression by gene transfer of adenoviral IγBβ. Surgery 126: 142–147
Ganster RW, Geller DA (2000) Molecular regulation of inducible nitric oxide synthase. In: L Ignarro (ed): Nitric oxide. Academic Press, San Diego, 129–156
Montgomery KF, Osborn, L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM, Pohlman TH (1991) Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natt Acad Sci USA 88: 6523–6527
Neish AS, Williams AJ, Palmer HJ, Whitley MZ, Collins T (1992) Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 176: 1583–1593
Voraberger G, Schafer R, Stratowa, C (1991) Cloning of the human gene for intracellular adhesion molecule 1 and analysis of its 5’-regulatory region. Induction by cytokines and phobol ester. J Immunol 147: 2777–27786
Mukaida N, Mahe Y, Matsushima K (1990) Cooperative interaction of nuclear factor-kappa B-and cis regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265: 21128–21133
Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, Gray JG (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a non-consensus CRE-like site. J Immunol 153(2): 712–723
Zhang L, Nabel GJ (1994) Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites. Cytokines 6(3): 221–228
Ohmori Y, Schreiber RD, Hamilton TA (1997) Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem 272: 14899–14907
Kleinert H, Wallerath T, Fritz G, Ihrig-Biedert I, Geller D, Forstermann U (1998) Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1, and NF-γB-signaling pathways. Br J Pharmacol 125(1): 193–201
Shaw G, Kamen R (1986) A conserved AU sequence from the 3’ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659–667
Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Serami A (1986) Identification of a common nucleotide sequence in the 3’-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83: 1670–1674
Han J, Brown T, Beutler B (1990) Endotoxin-reponsive sequences control cachectin/ tumor necrosis factor biosynthesis at the translational level. J Exp Med 171: 465–475
Nunokawa, Y, Oikawa, S, Tanaka, S (1996) Expression of human inducible nitric oxide synthase is regulated by both promoter and 3’-regions. Biochem Biophys Res Commun 223, 347–352
Kleinert H, Rodriguez-Pascual F, Hausding M, Furneaux H, Levy AP, Forstermann U (2000) Regulation of the expression of the human inducible nitric oxide synthase gene by the RNA-binding protein HuR. Nitric Oxide: Biology and Chemistry 4: 258
Chu SC, Wu HP, Banks TC, Eissa NT, Moss J (1995) Structural diversity in the 5’-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA. J Biol Chem 270: 10625–10630
Eissa NT, Strauss AJ, Haggerty CM, Choo EK, Chu SC, Moss J (1996) Alternative splicing of human inducible nitric oxide synthase mRNA: tissue specific regulation and induction by cytokines. J Biol Chem 271(43): 27184–27187
Eissa NT, Yuan JW, Haggerty CM, Choo EK, Palmer CD, Moss J (1998) Cloning and characterizaion of human inducible nitric oxide synthase splic variant: A domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 95: 7625–7630
Pastor CM, Williams D, Yoneyama T, Hatakeyama K, Singleton, Naylor E, Billiar TR (1996) Competition for tetrahydrobiopterin between phenylalanine hydroxylase and nitric oxide synthase in rat liver. J Biol Chem 271: 24534–24538
Harada T, Kagamiyama H, Hatakeyama K (1993) Feedback regulation mechanisms for the control of GTP cyclohydrolase I activity. Science 260: 1507–1510
Knowles RG, Salter M, Brooks SL, Moncada S (1990) Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase. Biochem Biophys Res Commun 172: 1042–1048
Geller DA, Nussler AK, Di Silvio M, Lowenstein CL, Shapiro RA, Wang SC, Simmons RL, Billiar TR (1993) Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 90: 522–526
Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U (1996) Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor NF-γB. Mol Pharmacol 49: 15–21
de Vera ME, Taylor BS, Wang Q, Shapiro RA, Billiar TR, Geller DA (1997) Dexamethasone suppresses inducible nitric oxide synthase gene expression by upregulating I-γBα and inhibiting NF-γB. Am J Physiol 273: G1290–G1296
Salzman AL, Denenberg AG, Ueta I, O’Connor M, Linn SC, Szabo C (1996) Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 270: G565-G573
Perrella MA, Yoshizumi M, Fen Z, Tsai J-C, Hsieh C-M, Kourembanas S, Lee M-E (1994) Transforming growth factor-ß1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1ß in rat smooth muscle cells. J Biol Chem 269: 14595–14600
Kunz D, Walker G, Eberhardt W, Pfeilschifter J (1996) Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1ß-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci USA 93: 255–259
Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, Geller DA (1997) Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch of Surgery 132: 1177–1183
Park SK, Lin HL, Murphy S (1997) Nitric oxide regulates nitric oxide syntase-2 gene expression by inhibiting NF-γB binding to DNA. Biochem J 322: 609–613
Griscavage JM, Rogers NE, Sherman MP, Ignarro LJ (1993) Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J Immunol 151(11): 6329–6337
Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E Caldarera CM (1995) Induction of nitric oxide synthase mRNA expression. Suppression by nitric oxide. J Biol Chem 270(45): 26731–26733
Ambs S, Hussain SP, Harris C (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J 11: 443–448
Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, Felley-Bosco E, Wang XW, Geller DA, Tzeng E, Billiar TR, Harris CC (1996) Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci USA 93: 2442–2447
Ambs S, Ogunfusika M, Merriam W, Bennett WP, Billiar TR, Harris CC (1998) Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc Natl Acad Sci USA 95(15): 8823–8828
de Vera ME, Wong J, Zhou JY, Tzeng E, Wong H, Billiar TR, Geller DA (1996) Cytokine-induced nitric oxide synthesis in human liver cells is inhibited by the heat shock response. Surgery 120: 144–149
Feinstein DL, Galea E, Aquino DA, Li GC, Xu H, Reis DJ (1996) Heat shock protein 70 suppresses astroglial-inducible nitric oxide synthase expression by decreasing NF-γB activation. J Biol Chem 271: 17724–17732
Kim YM, de Vera ME Watkins SC, Billiar TR (1997) Nitric oxide protects cultured rat hepatocytes from TNFα-induced apoptsosis by inducing heat shock protein 70 expression. J Biol Chem 272: 1402–1411
Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimai S (1990) Macrophage deactivating factor and transforming growth factors-β1,-β2, and-β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 145: 940–946
Pfeilschifter J, Vosbeck K (1991) Transforming growth factor-β2 inihibits interleukin-1β and tumor necrosis factor-α induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 175: 372–375
Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CF (1992) Role of nitric oxide in antagonists effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endocrinol 6: 1921–1928
Perrella MA, Yoshizumi M, Fen Z, Tsai JC, Hseih CM, Kourembanas S, Lee ME (1994) Transforming growth factor-b1, but not dexamethasone, down regulates nitric oxide synthase mRNA after its induction by interleukin-1β in rat smooth muscle cells. J Biol Chem 269: 14595–14600
Perrella MA, Patterson C, Tan L, Yet SF, Hseih CM, Yoshizumi M, Lee ME (1996) Suppression of interleukin 1-b induced nitric oxide synthase promoter/enhancer activity by transforming growth-b in vascular smooth muscle cells. J Biol Chem 271: 13776–13780
Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C (1993) Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor-β. J Exp Med 178: 605–613
Nussler AK, Di Silvio M, Liu Z-Z, Geller DA, Freeswick PD, Dorko K, Bartoli F, Billiar T (1995) Further characterization and comparison of inducible nitric oxide synthase in mouse, rat and human hepatocytes. Hepatology 21: 1552–1560
Gilbert RS, Herschman HR (1993) Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem Biophys Res Commun 195: 380–384
Kleinert, H, Euchenhofer C, Ihrig-Biedert I, Forstermann U (1996) In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kappaB. J Biol Chem 271: 6039–6044
Liu ZZ, Cui S, Billiar TR, Dorko K, Halfter W, Geller DA, Michalopoulos G, Beger HG, Albina J, Nussler AK (1996) Effects of hepatocellular mitogens on cytokine-induced nitric oxide synthesis in human hepatocytes. J Leuk Biol 60: 382–388
Taylor BS, Liu S, Villavicencio RT, Ganster RW, Geller DA (1999) The role of protein of phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte. Hepatology 29: 1199–1207
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Basel AG
About this chapter
Cite this chapter
Taylor, B.S., Geller, D.A. (2001). Regulation of the inducible nitric oxide synthase (iNOS) gene. In: Salvemini, D., Billiar, T.R., Vodovotz, Y. (eds) Nitric Oxide and Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8241-5_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8241-5_1
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9488-3
Online ISBN: 978-3-0348-8241-5
eBook Packages: Springer Book Archive